Transforming Healthcare
Through Regenerative Medicine

 

Senior Scientific Advisors

Director, McGowan Institute for Regenerative Medicine; Executive Director, Pittsburgh Tissue Engineering Initiative; Director, National Tissue Engineering Center





Advisory Board

  • Anthony Atala, M.D. (Professor, Chair, Director, Institute for Regenerative Medicine at Wake Forest University ; Scientific Founder of Tengion and Plureon; Expertise: Tissue Engineering)
  • Jacqueline Brandwynne (Founder & CEO, Very Private; Yardley; Citicorp; Neutrogena; Member of the Board of The Los Angeles Opera, The California Institute of the Arts, and the " Amici degli Uffici" in Florence, Italy. Expertise: Business Planning and Aesthetic Medicine-Marketing)
  • Gordon Keller, Ph.D. (Professor, Gene and Cell Medicine at University of Toronto; Expertise: Growth and Differentiation of Human Embryonic Stem Cells)
  • Arnold R. Kriegstein, M.D. Ph.D., (Director, Program in Developmental and Stem Cell Biology and Professor of Neurology at the University of California, San Francisco)
  • Robert Lanza, Ph.D. (Vice President of Medical and Scientific Development, Advanced Cell Technology; SCNT, Cell Therapies and Differentiation; Authored numerous textbooks and peer reviewed articles on regenerative medicine)
  • Malcolm Moore, Ph.D. (Enid A. Haupt Chair of Cell Biology at Memorial Sloan-Kettering Cancer Center; Professor of Biology at Weill Cornell; Developer of Neupogen; human embryonic stem cells and differentiation.


Director, Regenerative Medicine Bioprocessing Unit, University College, London










  • Michael Longaker, M.D. M.B.A. (Deane P. and Louise Mitchell Professor Director, Children’s Surgical Research Department of Surgery; Director Stanford Initiative in Regenerative Medicine)
  • Gail Naughton, Ph.D (Dean of the College of Business Administration at San Diego State University since August 2002; Co-Founder and President of Advanced Tissue Sciences)
  • Julia Polak, Ph.D. (Professor and Director of Tissue Engineering and Regenerative Medicine Centre, Imperial College of London; Founder, Novathera; tissue engineering)
  • Wolf Reik, Ph.D. (Head, Laboratory of Developmental Genetics and Imprinting; Associate Director of Research Strategy at The Babraham Institute; epigenetics)
  • Brock Reeve, MBA (Executive Director, Harvard Stem Cells Institute)
  • Myron Spector , Ph.D. (Director, Orthopedic Research, Brigham and Women's Hospital; Director, Tissue Engineering, VA Boston Healthcare System; Professor, Harvard Medical School and MIT.)